Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Rhythm Pharmaceuticals Insider Sold Shares Worth $5,133,442, According to a Recent SEC Filing

Rhythm Pharmaceuticals Insider Sold Shares Worth $5,133,442, According to a Recent SEC Filing

MT newswireMT newswire2026/09/15 07:33
03:33 AM EDT, 09/15/2026 (MT Newswires) -- David P Meeker, Director, President and Chief Executive Officer, on September 14, 2026, sold 50,000 shares in Rhythm Pharmaceuticals (RYTM) for $5,133,442. Following the Form 4 filing with the SEC, Meeker has control over a total of 239,258 common shares of the company, with 239,258 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649904/000164990426000026/xslF345X05/form4.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Bank of America: S&P 500 is forming a bullish flag during consolidation, with a long-term target still above 8,000 points

Bank of America technical analysts remain bullish on the long-term uptrend, believing that the S&P 500 Index is likely to break above 8,000 points, despite a recent series of market and macroeconomic headwinds testing investor confidence.

智通财经2026/09/15 07:42
Bank of America: S&P 500 is forming a bullish flag during consolidation, with a long-term target still above 8,000 points